Compound 12
Identifiers
- Canonical SMILES:
Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1ccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1
- IUPAC name:
3,5-dichloro-N-[[4-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]phenyl]methyl]-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide
- InChi:
InChI=1S/C34H26Cl4F2N2O6S2/c35-25-13-29(37)33(43)31(15-25)49(45,46)41(19-23-5-9-27(39)10-6-23)17-21-1-2-22(4-3-21)18-42(20-24-7-11-28(40)12-8-24)50(47,48)32-16-26(36)14-30(38)34(32)44/h1-16,43-44H,17-20H2
- InChiKey:
UTRDJZHGWZOLRH-UHFFFAOYSA-N
External links
58531371 |
External search
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 96 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 8.00 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 800.00 g/mol | |||
HBA | 8 | |||
HBD | 2 | |||
HBA + HBD | 10 | |||
AlogP | 9.07 | |||
TPSA | 115.22 | |||
RB | 10 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 96 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.96 | |
WO2009152082 | 96 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 8.00 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6667 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4956 | Saccharin | DB12418 | |
0.4870 | Sulfabenzamide | DB09355 | |
0.4865 | 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide | DB02429 | |
0.4834 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4762 | Evatanepag | DB12022 | |
0.4701 | 4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide | DB04180 | |
0.4701 | 4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide | DB02221 | |
0.4609 | N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide | DB02069 | |
0.4576 | 4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide | DB02861 | |
0.4530 | N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide | DB03844 | |
0.4508 | 4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide | DB04549 | |
0.4494 | Avagacestat | DB11893 | |
0.4472 | N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide | DB02610 | |
0.4417 | 4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide | DB03039 |